)
Dr Layla Hosseini-Gerami
Co-Founder & Chief Data Science Officer,
Ignota Labs
Dr. Layla Hosseini-Gerami bridges the worlds of chemistry, biology, and AI in her role as Chief Data Science Officer at Ignota Labs. She has an undergraduate and masters degree in chemistry, winning Outstanding Graduate of the Year and was a finalist in the prestigious Salters awards. She then went on to earn a PhD at the University of Cambridge under the mentorship of Andreas Bender, a renowned figure in AI drug discovery. There she pioneered integrative cheminformatics and bioinformatics strategies for understanding drug molecular mechanisms, winning the Chemistry Theory Outstanding Thesis Award in 2023, and producing several publications in collaboration with Eli Lilly, leading industry translation of her academic research. At Ignota Labs, she has built upon these sophisticated methods to understand the mechanisms of drug toxicity and how to mitigate them. Her goal is to leverage AI not just to understand, but also to prevent adverse drug reactions, ensuring safer therapeutic options for patients.
Sessions
-
10-Jun-2025Impact StageGenerative AI for Drug Discovery